GC–MS Phytochemical Characterization and Comparative Antidiabetic Activities of Methanolic Extracts of Calotropis gigantea Leaves, Stem Bark, and Roots in Streptozotocin-Induced Diabetic Rats
Article Sidebar
Page Numbers:
176-206
Digital Object Identifier:
10.58578/ajstm.v3i3.11828
Viewed: 0 times
Downloaded: 0 times
LYAS Publisher cordially invites qualified professionals to serve as Editors or Reviewers. Your expertise will make an important contribution to maintaining and strengthening the academic quality of our publications. Interested applicants are kindly requested to complete the application form at the following link: Editors & Reviewers
Please feel free to contact us if you need any further information about the submission process or if you have any additional questions.
Authors:Mercy iliya Tumba1*, Isaac John Umaru2, Chinedu Imo3
Copyright :Authors retain copyright and grant the journal right of first publication.
Main Article Content
Abstract
Calotropis gigantea is widely used in traditional medicine for treating various health conditions. This study evaluated the phytochemical composition and comparative therapeutic effects of methanolic extracts from its leaves, stem bark, and roots in streptozotocin (STZ)-induced diabetic albino rats. Plant materials were air-dried, pulverized, and extracted through cold maceration in methanol for 72 hours, after which the extracts were concentrated using a rotary evaporator and characterized by gas chromatography–mass spectrometry (GC–MS). Thirty-six male albino rats were randomly assigned to six groups: normal control, diabetic control, metformin-treated (100 mg/kg), and leaf-, stem-bark-, and root-extract-treated groups (100 mg/kg each). Treatments were administered for 14 days. Fasting blood glucose, liver and kidney function indices, and lipid profiles were assessed, alongside histopathological examination of liver and kidney tissues. GC–MS identified several bioactive compounds, including the oxygenated monoterpenes 7-octen-2-ol, α-terpineol, and D-limonene, indicating potential antioxidant relevance. Diabetes induction increased fasting blood glucose from 4.93 ± 0.25 to 16.14 ± 0.98 mmol/L, and concentrations remained elevated in untreated diabetic rats. All extracts significantly reduced blood glucose, with the root extract producing the greatest reduction, from 15.37 ± 1.10 to 8.93 ± 1.94 mmol/L, comparable to the response observed with metformin. The root and leaf extracts demonstrated the strongest improvements in renal function indices, whereas the leaf extract produced the most pronounced reductions in alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase activities. The leaf extract also reduced serum triglyceride and cholesterol concentrations while increasing high-density lipoprotein levels. Histopathological findings corroborated the biochemical results by demonstrating reduced liver and kidney tissue damage in treated animals. These findings indicate that C. gigantea, particularly its root and leaf extracts, possesses antidiabetic, hepatoprotective, nephroprotective, and lipid-modulating potential, supporting its further investigation as a candidate for managing diabetes mellitus and its associated complications.
Citation Metrics:
Downloads
Citation Metrics & Similar Scopus Articles
-
Sheng T. (2027)Photothermal Superhydrophobic Textiles: An Emerging Paradigm from Passive Water Repellency to Active Thermal ManagementNano Micro Letters, 19(1)
-
Zhao Y. (2027)Atomic High-Spin Cobalt Unlocks Reversible Multi-Electron Transfer Chemistry for Superb Aqueous Zn-Mn BatteriesNano Micro Letters, 19(1)
-
Cao Y. (2027)Biomimetic PD-1-Functionalized Immunostimulatory Nanomedicine Enables STING Activation and Durable Antitumor Immunity in Hepatocellular CarcinomaNano Micro Letters, 19(1)
Article Details
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
Alafnan, A., El-Saber, G., & El-Badry, A. (2021). Hepatoprotective and antioxidant effects of Calotropis gigantea in experimental models. Saudi Journal of Biological Sciences, 28(5), 2789–2798.
Ali, M., Khan, R., & Ahmad, S. (2018). Phytochemical variations in different parts of Calotropis gigantea and their pharmacological significance. Journal of Ethnopharmacology, 215(2), 145–156.
American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus. Diabetes Care, 37(Supplement 1), S81–S90. https://doi.org/10.2337/dc14-S081
Atta, A., El-Sayed, M., & Hassan, H. (2021). Diabetic nephropathy: Mechanisms and therapeutic approaches. Nephrology Research, 15(2), 89–104.
Bello, I., Mohammed, S., & Ibrahim, A. (2022). Diabetes-induced hepatotoxicity: Mechanisms and intervention strategies. Journal of Diabetes Research, 2022, 1–15.
Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N. S., Montales, M. T., Kuriakose, K., Sasapu, A., Beebe, A., Patil, N., Musham, C. K., Lohani, G. P., & Mirza, W. (2017). Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Frontiers in Endocrinology, 8, 6. https://doi.org/10.3389/fendo.2017.00006
Chen, W., Zhang, H., & Wang, Y. (2020). Oxidative stress and hepatic injury in diabetes mellitus. World Journal of Hepatology, 12(8), 451–465.
Devi, R., Kumar, P., & Singh, S. (2020). Comparative antidiabetic evaluation of different parts of Calotropis gigantea. Asian Journal of Pharmaceutical Research, 10(4), 235–242.
Dwivedi, V., Singh, A., & Mishra, R. (2024). Environmental factors affecting phytochemical composition and bioactivity of medicinal plants. Phytochemistry Reviews, 23(1), 45–68.
Ekor, M. (2014). The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, 177. https://doi.org/10.3389/fphar.2013.00177
Forouhi, N. G., & Wareham, N. J. (2014). Epidemiology of diabetes. Medicine, 42(12), 698–702. https://doi.org/10.1016/j.mpmed.2014.09.007
Gomathi, K., Manimekalai, P., & Kumar, G. (2018). GC–MS analysis of bioactive compounds in medicinal plants: A review. Journal of Analytical Science, 12(3), 189–202.
Goyal, S. N., Sharma, A., & Rastogi, S. (2016). Streptozotocin-induced diabetes in rats: A comprehensive review. Journal of Diabetes Research, 2016, 1–15.
Gupta, R., Sharma, M., & Patel, S. (2021). Mechanistic insights into the antidiabetic activity of phytochemicals from Calotropis gigantea. Phytotherapy Research, 35(6), 3210–3225.
Gupta, V., Singh, A., & Kumar, R. (2024). Monoterpenes in diabetes management: Therapeutic potential and mechanisms. Journal of Natural Products, 87(3), 456–472.
International Diabetes Federation. (2019). IDF diabetes atlas (9th ed.). https://diabetesatlas.org
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015). Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach—Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 38(1), 140–149. https://doi.org/10.2337/dc14-2441
Islam, M. S., & Choi, H. (2009). Comparative effects of dietary supplementation with different phytochemicals in streptozotocin-induced diabetic rats. Journal of Medicinal Food, 12(5), 1017–1025.
Jain, S., Sharma, P., & Mehta, N. (2022). Phytochemical profile and pharmacological activities of Calotropis gigantea: A systematic review. Journal of Herbal Medicine, 34, 100678.
Jena, P., Mohanty, S., & Das, S. (2025). Enzyme inhibitory effects of terpenoid-rich extracts from Calotropis gigantea. Journal of Ethnopharmacology, 256(1), 112–126.
Kareem, A., Rajesh, M., & Gupta, S. (2019). Distribution and traditional uses of Calotropis gigantea in tropical regions. Ethnobotany Research and Applications, 18(6), 1–12.
Khan, M., Ahmed, S., & Rahman, M. (2025). Renal protective effects of medicinal plants in diabetic nephropathy. Journal of Nephrology, 38(2), 278–295.
Kumar, A., Singh, S., & Singh, R. (2013). Calotropis gigantea: A review on its ethnobotany, phytochemistry, and pharmacology. Pharmaceutical Biology, 51(10), 1340–1355.
Kumar, P., Singh, D., & Sharma, R. (2021). GC–MS characterization and antidiabetic evaluation of Calotropis gigantea extracts. Journal of Pharmaceutical Analysis, 11(4), 502–515.
Lenzen, S. (2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia, 51(2), 216–226. https://doi.org/10.1007/s00125-007-0886-7
Murti, Y., Yogi, B., & Pathak, A. (2010). Pharmacological properties of Calotropis gigantea: A review. International Journal of PharmTech Research, 2(2), 1045–1051.
Newman, D. J., & Cragg, G. M. (2016). Natural products as sources of new drugs from 1981 to 2014. Journal of Natural Products, 79(3), 629–661. https://doi.org/10.1021/acs.jnatprod.5b01055
Nexres Review. (2026). Therapeutic potential of Calotropis gigantea in oxidative stress-related diseases. Nexres Pharmacology Review, 12(2), 89–104.
Patil, R., & Jain, A. (2019). Antidiabetic and antioxidant activities of Calotropis gigantea: A comprehensive review. Journal of Herbal Pharmacotherapy, 19(3), 210–225.
Rajput, P., Singh, A., & Singh, S. (2020). Mechanisms of phytochemical action in diabetes management. Phytomedicine, 68(2), 153–168.
Ram, R., Kumar, V., & Sharma, S. (2023). Comparative analysis of bioactive compounds in different parts of Calotropis gigantea. Journal of Natural Remedies, 23(1), 45–56.
Rao, S., Nair, M., & Singh, P. (2022). Integration of GC–MS and in vivo pharmacological studies in medicinal plant research. Phytochemical Analysis, 33(5), 689–704.
Sarker, S. D., Nahar, L., & Sarker, S. (2020). Gas chromatography–mass spectrometry in phytochemical analysis. Phytochemistry Reviews, 19(4), 845–867.
Sawong, R., Thongrakard, T., & Srisawat, P. (2022). Histopathology of drug-induced liver injury in experimental models. Toxicology Reports, 9(3), 245–258.
Sharma, A., Gupta, P., & Singh, R. (2023). Histological and biochemical correlation in evaluating hepatoprotective activity. Journal of Pharmacology and Toxicology, 18(4), 512–528.
Sharma, R., Kumar, A., & Singh, R. (2020). Therapeutic potential of Calotropis gigantea in oxidative stress and inflammation. Journal of Inflammation Research, 13(1), 123–138.
Singh, D., & Rastogi, R. (2021). Phytochemical diversity in Calotropis gigantea: Implications for therapeutic applications. Journal of Medicinal Plants Research, 15(8), 345–362.
Singh, P., Kumar, R., & Sharma, S. (2023). Terpenoid-rich extracts from Calotropis gigantea: Antioxidant and antidiabetic activities. Journal of Ethnopharmacology, 305(1), 116–132.
Srivastava, A., Kumar, N., & Singh, R. (2019). Application of GC–MS in phytochemical profiling of medicinal plants. Journal of Chromatography A, 1587(1), 89–104.
Szkudelski, T. (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological Research, 50(6), 537–546.
World Health Organization. (2016). Global report on diabetes. https://www.who.int/publications/i/item/9789241565257